TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19047882

Group type: EXPERIMENTAL
Intervention: Electronic Self Report Assessment‐Cancer (ESRA‐C) program on wireless laptops with touch-screen format
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Electronic Self Report Assessment‐Cancer (ESRA‐C) program
Number of subjects: 342
Study: 17023243

Group type: EXPERIMENTAL
Intervention: Accelerometry monitoring of arm activity
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Actual Amount of Use Test (AAUT)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Motor Activity Log (MAL)
Number of subjects: 169
Study: 12787692

Group type: EXPERIMENTAL
Intervention: 100% oxygen (treatment group)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Air (control group)
Number of subjects: 18
Study: 12579906

Group type: EXPERIMENTAL
Intervention: Shunt tube implantation combining amniotic membrane transplantation
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Shunt tube with amniotic supporter and amniotic membrane transplantation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Single plate Molteno implant
Number of subjects: 41
Study: 8672373

Group type: EXPERIMENTAL
Intervention: Fentanyl preloaded bypass pump
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% saline preloaded bypass pump
Number of subjects: 0
Study: 1794303

Group type: EXPERIMENTAL
Intervention: Lyophilized type I collagen (LC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hyaluronic acid medicated gauze
Number of subjects: 20
Study: 6387183

Group type: EXPERIMENTAL
Intervention: 1-day treatment regimen
Number of subjects: 58

Group type: COMPARATOR
Intervention: 10-day treatment regimen
Number of subjects: 58
Study: 3955903

Group type: EXPERIMENTAL
Intervention: More frequent clinical follow-ups (once a month)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Improved blood pressure control
Number of subjects: 17
Study: 31432723

Group type: EXPERIMENTAL
Intervention: RSVH infants
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: UBH infants
Number of subjects: 1000000

Group type: COMPARATOR
Intervention: Comparator infants
Number of subjects: 1000000
Study: 30065275

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 85
Study: 27599622

Group type: EXPERIMENTAL
Intervention: Motor Control Exercise (MCE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Stretching Exercise (SE)
Number of subjects: 36
Study: 24680372

Group type: EXPERIMENTAL
Intervention: Suvorexant (40 mg for patients younger than 65 years, 30 mg for patients aged 65 years or older)
Number of subjects: 781

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Suvorexant
Number of subjects: 781
Study: 22508924

Group type: EXPERIMENTAL
Intervention: 5 S's (swaddling, side/stomach position, shushing, swinging, and sucking)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 5 S's with sucrose (24% oral sucrose)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Sucrose alone (2 mL of 24% oral sucrose)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control (2 mL of water with standard-of-care comfort measures)
Number of subjects: 230
Study: 20820114

Group type: EXPERIMENTAL
Intervention: Special mouth care with essential oil (geranium, lavender, tea tree, and peppermint) applied twice daily for one week
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.9% saline mouth care applied twice daily for one week
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Special mouth care with essential oil
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.9% saline mouth care
Number of subjects: 43
Study: 18210330

Group type: EXPERIMENTAL
Intervention: tibolone 2.5 mg daily for 16 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol 2 mg daily for 16 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no hormone therapy)
Number of subjects: 45
Study: 15665181

Group type: EXPERIMENTAL
Intervention: Comminuted chicken diet with Benefiber (study diet)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Comminuted chicken diet without Benefiber (control diet)
Number of subjects: 116
Study: 12682324

Group type: COMPARATOR
Intervention: Normalized cortical volumes (NCV) in RR MS patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normalized cortical volumes (NCV) in PP MS patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of NCV with Expanded Disability Status Scale scores in PP MS patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of NCV with Expanded Disability Status Scale scores in RR MS patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of NCV with T2-weighted lesion volume in RR MS patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of NCV with disease duration in RR MS patients
Number of subjects: 0
Study: 10608480

Group type: EXPERIMENTAL
Intervention: Perindopril and indapamide (for those without contraindications)
Number of subjects: 6105

Group type: EXPERIMENTAL
Intervention: Perindopril alone
Number of subjects: 6105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6105
Study: 9012161

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy for insomnia (IPT‐I)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Progressive relaxation training (PR)
Number of subjects: 25
Study: 1667334

Group type: EXPERIMENTAL
Intervention: Baclofen (10 mg PO at 0830h)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison of GH response
Number of subjects: 19
Study: 6406531

Group type: EXPERIMENTAL
Intervention: Phosphate therapy (8.5 mmol/h or approximately 6 g phosphate/24 h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No phosphate therapy (control group)
Number of subjects: 30
Study: 31747951

Group type: EXPERIMENTAL
Intervention: PedAMINES app
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional calculation methods
Number of subjects: 120
Study: 29553785

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: HADS-Depression
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: MSWS-12
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 59
Study: 26992841

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3-mg injections
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5-mg injections
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Ranibizumab (both dosages)
Number of subjects: 681

Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 681
Study: 24708645

Group type: EXPERIMENTAL
Intervention: First-line antiretroviral therapy (ART)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Baseline genotyping for HIV drug resistance (HIVDR)
Number of subjects: 265
Study: 23067427

Group type: EXPERIMENTAL
Intervention: Full CPT protocol (n = 44)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Cognitive therapy component of CPT (n = 39)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Written account component of CPT (n = 43)
Number of subjects: 126
Study: 20450930

Group type: EXPERIMENTAL
Intervention: Narrative skin cancer message
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Non-narrative skin cancer message
Number of subjects: 230

Group type: COMPARATOR
Intervention: No-message control condition
Number of subjects: 230
Study: 18630541

Group type: EXPERIMENTAL
Intervention: Lifting-thrusting group (n = 37)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Twirling group (n = 36)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Routine needling group (n = 34)
Number of subjects: 107
Study: 16160130

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (n = 577)
Number of subjects: 1156

Group type: COMPARATOR
Intervention: Bare metal stents (n = 579)
Number of subjects: 1156
Study: 11454122

Group type: EXPERIMENTAL
Intervention: Oral estrogen (0.625 mg) combined with progesterone (2.5 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 9548613

Group type: EXPERIMENTAL
Intervention: Lansoprazole, amoxicillin, and clarithromycin triple therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8047821

Group type: EXPERIMENTAL
Intervention: Combination of amoxycillin (3 g daily), metronidazole (1 g daily), and omeprazole (20 mg daily)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 73
Study: 2738215

Group type: EXPERIMENTAL
Intervention: Three-session skills-training program
Number of subjects: 744

Group type: COMPARATOR
Intervention: Three-session discussion control condition
Number of subjects: 744

Group type: COMPARATOR
Intervention: No-treatment control condition
Number of subjects: 744
Study: 1100789

Group type: EXPERIMENTAL
Intervention: Metrizamide
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Meglumine iocarmate (Dimer‐X)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: EEG, routine laboratory analyses of CSF, neurologic examinations
Number of subjects: 86
Study: 30007300

Group type: EXPERIMENTAL
Intervention: 0.018-inch slot orthodontic bracket system
Number of subjects: 187

Group type: COMPARATOR
Intervention: 0.022-inch slot orthodontic bracket system
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 187
Study: 28854376

Group type: EXPERIMENTAL
Intervention: Ambient light
Number of subjects: 357

Group type: COMPARATOR
Intervention: Darkened room
Number of subjects: 357
Study: 27021544

Group type: EXPERIMENTAL
Intervention: benzethonium chloride (BZC) gargle
Number of subjects: 29

Group type: COMPARATOR
Intervention: placebo gargle
Number of subjects: 29

Group type: COMPARATOR
Intervention: no gargle
Number of subjects: 29
Study: 25077855

Group type: EXPERIMENTAL
Intervention: Religious involvement
Number of subjects: 129
Study: 22512348

Group type: EXPERIMENTAL
Intervention: Active tDCS (10 sessions, 20 minutes, 2 mA over 4 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham tDCS (10 sessions, 20 minutes, 2 mA over 4 weeks)
Number of subjects: 13
Study: 19846027

Group type: EXPERIMENTAL
Intervention: Febuxostat (80 mg or 120 mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allopurinol (300/100 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 0
Study: 17464087

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell (BMC) transplantation and GM-CSF administration (n = 17, 14 days post-injury)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell (BMC) transplantation and GM-CSF administration (n = 6, between 14 days and 8 weeks post-injury)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell (BMC) transplantation and GM-CSF administration (n = 12, more than 8 weeks post-injury)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (n = 13) treated with conventional decompression and fusion surgery without BMC transplantation
Number of subjects: 35
Study: 15044639

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus autologous stem-cell transplantation
Number of subjects: 197

Group type: COMPARATOR
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus autologous stem-cell transplantation (for high intermediate risk patients)
Number of subjects: 197

Group type: COMPARATOR
Intervention: CHOP (for high intermediate risk patients)
Number of subjects: 197
Study: 11449213

Group type: EXPERIMENTAL
Intervention: Lateral positioning (right and left 45 degrees lateral and supine)
Number of subjects: 12
Study: 9018019

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amantadine
Number of subjects: 30
Study: 8519044

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg or 20 mg
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg plus hydrochlorothiazide 25 mg
Number of subjects: 217

Group type: COMPARATOR
Intervention: Enalapril 10 mg
Number of subjects: 217
Study: 3033339

Group type: EXPERIMENTAL
Intervention: Nonoxynol 9-impregnated contraceptive sponge
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group (nonusers of the sponge)
Number of subjects: 434
Study: 31009802

Group type: EXPERIMENTAL
Intervention: Auditory cues during navigation
Number of subjects: 22

Group type: COMPARATOR
Intervention: No auditory cues during navigation
Number of subjects: 22
Study: 29107706

Group type: EXPERIMENTAL
Intervention: Body weight‐supported treadmill training (BWSTT) with real tDCS (1mA, 20min) on SMA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Body weight‐supported treadmill training (BWSTT) with sham stimulation
Number of subjects: 30
Study: 27424661

Group type: EXPERIMENTAL
Intervention: unmodified fish oil TAG (uTAG)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: free fatty acids (FFA)
Number of subjects: 29

Group type: COMPARATOR
Intervention: re-esterified TAG
Number of subjects: 29

Group type: COMPARATOR
Intervention: ethyl esters (EE)
Number of subjects: 29
Study: 25286015

Group type: EXPERIMENTAL
Intervention: Edaravone (MCI-186)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 22573135

Group type: EXPERIMENTAL
Intervention: Total osteocalcin (OCN)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Carboxylated osteocalcin
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Under-carboxylated osteocalcin
Number of subjects: 137
Study: 20722845

Group type: EXPERIMENTAL
Intervention: Interdisciplinary program of geriatric consultation, continuous rehabilitation, and discharge planning
Number of subjects: 162

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 162
Study: 19000191

Group type: EXPERIMENTAL
Intervention: Combination therapy (ER:YAG laser ablation + 5FU application + NB-UVB therapy)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mono-therapy (NB-UVB therapy only)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 50
Study: 16640106

Group type: EXPERIMENTAL
Intervention: 3TC (4 mg/kg/day, max 100 mg) started simultaneously with IFN‐alpha2a for 6 months (group I)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: 3TC started 2 months prior to IFN‐alpha2a for 6 months (group II)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 177
Study: 12812880

Group type: EXPERIMENTAL
Intervention: Manual Small Incision Cataract Surgery (MSICS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracapsular Cataract Extraction (ECCE)
Number of subjects: 0
Study: 10638902

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diphenhydramine (control)
Number of subjects: 16
Study: 8858404

Group type: EXPERIMENTAL
Intervention: Concentric-only leg extension DCER exercise (3-5 sets of 6 repetitions at 80% of one-repetition maximum load) for eight weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Concentric-only leg extension DCER exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 16
Study: 7679273

Group type: EXPERIMENTAL
Intervention: Telephone intervention for patients with osteoarthritis
Number of subjects: 0
Study: 3440643

Group type: EXPERIMENTAL
Intervention: Microporous colestyramine (MPC) 9 g/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Microporous colestyramine (MPC) 12 g
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Microporous colestyramine (MPC) 18 g
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29802966

Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information, genetic counselor phone call, educational booklet on melanoma prevention
Number of subjects: 892

Group type: COMPARATOR
Intervention: Educational booklet on melanoma prevention
Number of subjects: 892
Study: 26324284

Group type: EXPERIMENTAL
Intervention: Preemptive multimodal analgesic regimen (celecoxib, pregabalin, extended‐release oxycodone, and acetaminophen)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 80
Study: 25182377

Group type: EXPERIMENTAL
Intervention: HF-NMES (75 Hz)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LF-NMES (15 Hz)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 22131049

Group type: EXPERIMENTAL
Intervention: Gray-scale ultrasound (US) scoring system
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound (PDUS) scoring system
Number of subjects: 62

Group type: COMPARATOR
Intervention: Clinical indices
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Gray-scale US and PDUS
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Simplified scoring system referring to gray-scale US and PDUS findings
Number of subjects: 62
Study: 17894152

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (nonscented baby oil)
Number of subjects: 54
Study: 15645698

Group type: EXPERIMENTAL
Intervention: Insulin dosage calculation device (IDC)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (conventional methods)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups combined (months 6-12)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study: 12503831

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dothiepin (75 mg/day for 1 week followed by 150 mg/day for 4 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9692699

Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg o.m.
Number of subjects: 156

Group type: COMPARATOR
Intervention: Cimetidine 800 mg nocte
Number of subjects: 156
Study: 7937784

Group type: EXPERIMENTAL
Intervention: HIV-1-infected persons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rhesus macaques infected with pathogenic strain of SIV
Number of subjects: 0

Group type: COMPARATOR
Intervention: SIV-infected African green monkeys
Number of subjects: 0
Study: 2895761

Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temazepam 30 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29535280

Group type: EXPERIMENTAL
Intervention: Aromatherapy (inhalation of aroma oil blended with lavender, ylang-ylang, and neroli at a ratio of 4:2:1, twice before and after CAG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no aromatherapy)
Number of subjects: 64
Study: 26785764

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 1815
Study: 26232144

Group type: EXPERIMENTAL
Intervention: Nursing intervention (active observation and resolution of breastfeeding problems)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100
Study: 23725162

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Transcatheter arterial infusion (TAI)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial embolization (TAE)
Number of subjects: 418
Study: 20605308

Group type: EXPERIMENTAL
Intervention: Implants with platform switching (test)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control implants with horizontally matching implant-abutment connection (control)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Comparison between test and control implants
Number of subjects: 4
Study: 18206919

Group type: EXPERIMENTAL
Intervention: 10 mg bremelanotide as an intranasal spray
Number of subjects: 342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study: 16391889

Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasonography (PDU)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC)
Number of subjects: 41
Study: 14666019

Group type: EXPERIMENTAL
Intervention: Dynamic bubble trap (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo dynamic bubble trap (group 2)
Number of subjects: 50
Study: 11104110

Group type: COMPARATOR
Intervention: 0 mg nicotine gum
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 30
Study: 8625682

Group type: EXPERIMENTAL
Intervention: Milrinone loading dose of 25 micrograms/kg (LOW) followed by infusion of 0.5 microgram/kg/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Milrinone loading dose of 50 micrograms/kg (MED) followed by infusion of 0.5 microgram/kg/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Milrinone loading dose of 75 micrograms/kg (HIGH) followed by infusion of 0.5 microgram/kg/min
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Milrinone administration (all doses)
Number of subjects: 24
Study: 1524334

Group type: EXPERIMENTAL
Intervention: Advance directive (California Durable Power of Attorney)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group (no advance directive offered)
Number of subjects: 204
Study: 6489414

Group type: EXPERIMENTAL
Intervention: Cisapride (novel enterokinetic agent)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30708075

Group type: EXPERIMENTAL
Intervention: Intravenous adrenaline
Number of subjects: 170

Group type: COMPARATOR
Intervention: Advanced life support (ALS)
Number of subjects: 170
Study: 28941281

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement (GIC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zinc polycarboxylate cement (ZPC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dual-cured resin composite (DCRC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prepared but unrestored (control)
Number of subjects: 100
Study: 26822542

Group type: EXPERIMENTAL
Intervention: Mindfulness inducing intervention (15 minutes)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Mindfulness (correlational study)
Number of subjects: 309